VP of BioCubaFarma Discuss Partnerships, COVID-19, and the Future of the Company—Dr. Mayda Mauri Pérez

T. K. Hernández ()

Chapter Chapter 31 in The Cuba Interviews, 2023, pp 311-319 from Springer

Abstract: Abstract Part VIII explores Cuba’s priority sectors: health, medical tourism, and biopharmaceuticals. It provides industry insights from doctors, executives, and an editor of a peer-reviewed medical journal. These interviews highlight the successes of the healthcare system, research and collaboration, investments, pharmaceuticals, vaccine development, joint ventures, and medical tourism. This chapter is a conversation held with Dr. Mayda Mauri Pérez, Vice President of BioCubaFarma. Dr. Mauri has worked in the biotech sector for over 27 years. In 2012, she was one of the founding members of the BioCubaFarma business group. The company oversees 32 research and development, pharmaceutical manufacturing, and medical equipment businesses, exporting products to over 40 countries. This interview took place in July 2020 during the pandemic lockdowns. The focus is BioCubaFarma’s international collaborations, the clinical trials of CIMAvax-EGF in U.S. cancer patients at the Roswell Park Cancer Center, and those with China and Russia. Dr. Mauri discusses the future direction of BioCubaFarma, its product portfolio, challenges and successes during the pandemic, and COVID-19 drug trials. She also speaks of the potential for international investor partnerships, especially those found in the biopharmaceutical hub in the Mariel Special Development Zone (ZEDM).

Keywords: Cuba; Healthcare; Medical tourism; Biopharmaceuticals; BioCubaFarma; Foreign investment; Dr. Mayda Mauri (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-30203-9_31

Ordering information: This item can be ordered from
http://www.springer.com/9783031302039

DOI: 10.1007/978-3-031-30203-9_31

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().